Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma (Q36097706)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma |
scientific article |
Statements
1 reference
Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma (English)
1 reference
David R Gandara
1 reference
Everett E Vokes
1 reference
Pasi A Jänne
1 reference
Hedy L Kindler
1 reference
Theodore G Karrison
1 reference
Charles Lu
1 reference
Lee M Krug
1 reference
James P Stevenson
1 reference
David I Quinn
1 reference
Marianna N Koczywas
1 reference
Julie R Brahmer
1 reference
Kathy S Albain
1 reference
David A Taber
1 reference
Samuel G Armato
1 reference
Nicholas J Vogelzang
1 reference
Helen X Chen
1 reference
Walter M Stadler
1 reference
4 June 2012
1 reference
1 reference
2509-2515
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference